Range of plasma brain natriuretic peptide (BNP) levels in hemodialysis patients at a high risk of 1-year mortality and their relationship with the nutritional status: a retrospective cohort study in one institute

被引:2
作者
Kumagai, Etsuko [1 ,2 ]
Hosohata, Keiko [3 ]
Furumachi, Kazuhiro [1 ]
Takai, Shinji [2 ]
机构
[1] Kenwakai Hosp, 1936 Kanaenakadaira, Nagano 3950801, Japan
[2] Osaka Med Coll, Dept Innovat Med, 2-7 Daigakucho, Takatsuki, Osaka 5698686, Japan
[3] Osaka Univ Pharmaceut Sci, Educ & Res Ctr Clin Pharm, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan
关键词
Brain natriuretic peptide; Hemodialysis; Mortality; Nutritional status; HEART-FAILURE; SERUM PREALBUMIN; DIALYSIS; CACHEXIA; MASS; SURVIVAL; OVERLOAD;
D O I
10.1186/s41100-020-00280-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Brain natriuretic peptide (BNP) levels are used as a marker of heart failure, which is the leading cause of morbidity and mortality in dialysis patients. BNP levels increase as renal function declines. The range of BNP levels associated with satisfactory longevity in dialysis patients currently remains unknown. Methods In total, 660 patients receiving maintenance hemodialysis were enrolled. BNP levels were measured at the end of the year and in a follow-up to assess 1-year mortality between 2008 and 2012. Patients were divided into six groups according to BNP levels: < 50 (reference), 50 to < 100, 100 to < 300, 300 to < 500, 500 to < 1000, and >= 1000 pg/mL. One-year mortality at each BNP level was analyzed using Cox's proportional hazards model after adjustments for confounding factors. Results During the follow-up period, 78 (11.8%) deaths were recorded. After adjustments for confounding factors, such as gender, age, hemodialysis vintage, and primary disease, the risk of 1-year mortality was significantly high with BNP levels of 500 to < 1000 (hazard ratio [HR] 3.010; 95% confidence interval [CI] 1.065-10.729; P = 0.037) and more than 1000 pg/mL (HR 5.291; 95%CI 2.014-18.170; P = 0.0003). After adjustments for Kt/V, the risk of 1-year mortality was also significantly high with BNP levels of 500 to < 1000 (HR 3.045; 95%CI 1.065-10.929; P = 0.037) and more than 1000 pg/mL (HR 5.221; 95%CI 1.943-18.165; P = 0.0006). Following further adjustments for nutritional factors, such as albumin levels, total cholesterol levels, the normalized protein catabolic rate (nPCR), body mass index (BMI), and percent creatinine generation rate (%CGR), BNP levels of 500-1000 (HR 1.990; 95%CI 0.639-7.570; P = 0.244), and more than 1000 pg/mL (HR 2.100; 95%CI 0.663-8.105; P = 0.213) were no longer risk factors. Conclusion In dialysis patients, a BNP level >= 500 pg/mL is a risk factor for 1-year mortality. The risk associated with high BNP levels is reduced by nutritional factors, which suggests a relationship between high BNP levels and the nutritional status. In conclusion, efforts are needed to maintain BNP levels at lower than 500 pg/mL and improve the nutritional status.
引用
收藏
页数:9
相关论文
共 25 条
[1]   Nutritional Interventions in Heart Failure: A Systematic Review of the Literature [J].
Abshire, Martha ;
Xu, Jiayun ;
Baptiste, Diana ;
Almansa, Johana R. ;
Xu, Jingzhi ;
Cummings, Abby ;
Andrews, Martha J. ;
Himmelfarb, Cheryl Dennison .
JOURNAL OF CARDIAC FAILURE, 2015, 21 (12) :989-999
[2]  
Anker SD, 1997, EUR HEART J, V18, P259
[3]   Significance of plasma B-type natriuretic peptide in hemodialysis patients: Blood sample timing and comorbidity burden [J].
Biasioli, Stefano ;
Zamperetti, Monica ;
Borin, Donata ;
Guidi, Giancesare ;
De Fanti, Emanuela ;
Schiavon, Renzo .
ASAIO JOURNAL, 2007, 53 (05) :587-591
[4]   Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients [J].
Chertow, GM ;
Ackert, K ;
Lew, NL ;
Lazarus, JM ;
Lowrie, EG .
KIDNEY INTERNATIONAL, 2000, 58 (06) :2512-2517
[5]   Cachexia: A new definition [J].
Evans, William J. ;
Morley, John E. ;
Argiles, Josep ;
Bales, Connie ;
Baracos, Vickie ;
Guttridge, Denis ;
Jatoi, Aminah ;
Kalantar-Zadeh, Kamyar ;
Lochs, Herbert ;
Mantovani, Giovanni ;
Marks, Daniel ;
Mitch, William E. ;
Muscaritoli, Maurizio ;
Najand, Armine ;
Ponikowski, Piotr ;
Rossi Fanelli, Filippo ;
Schambelan, Morrie ;
Schols, Annemie ;
Schuster, Michael ;
Thomas, David ;
Wolfe, Robert ;
Anker, Stefan D. ;
Boyce, Amanda ;
Nuckolls, Glen .
CLINICAL NUTRITION, 2008, 27 (06) :793-799
[6]  
Hashimoto K., 1997, J JAPANESE SOC DIALY, V30, P117, DOI [10.4009/jsdt.30.117, DOI 10.4009/JSDT.30.117]
[7]  
Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x
[8]   Nutritional Interventions in Heart Failure: Challenges and Opportunities [J].
Kerley C.P. .
Current Heart Failure Reports, 2018, 15 (3) :131-140
[9]   Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient [J].
Lee, SW ;
Song, JH ;
Kim, GA ;
Lim, HJ ;
Kim, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (06) :1257-1266
[10]   Diagnostic potential of cardiac natriuretic peptides in dialysis patients [J].
Mallamaci, F ;
Zoccali, C ;
Tripepi, G ;
Benedetto, FA ;
Parlongo, S ;
Cataliotti, A ;
Cutrupi, S ;
Giacone, G ;
Bellanuova, I ;
Stancanelli, B ;
Malatino, LS .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1559-1566